Skip to content

Clinical trials

Completed Lupus Erythematosus, Systemic trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lupus Erythematosus, Systemic Status: Completed Country / region: United States Clear all

242 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20013
20026
20038
20045
20055
20069
20079
200811
200910
201013
201111
201211
201314
201412
20159
201611
201717
201819
201910
20208
20216
202210
20235
20242
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed242

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen11
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)10
GlaxoSmithKline9
Bristol-Myers Squibb8
Duke University8
Medical University of South Carolina8
Human Genome Sciences Inc., a GSK Company6
NYU Langone Health6
National Institute of Allergy and Infectious Diseases (NIAID)6
Oklahoma Medical Research Foundation6

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lupus Erythematosus, Systemic242
Autoimmune Diseases27
Arthritis, Rheumatoid17
Lupus Nephritis13
Immune System Diseases11
Sjogren's Syndrome11
Arthritis9
Connective Tissue Diseases8
Atherosclerosis7
Lupus Erythematosus, Cutaneous7

Trials

Showing 1 to 25 of 242. Each trial links to its page on Pharma Observatory.

142 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.